Imiquimod: Clinical Trials

5 trials of Imiquimod, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 5
Phase 12Terminated 2

Follow Imiquimod: new trials by email Literature Review of Imiquimod trials Research Report on Imiquimod

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Imiquimod for Preventing Keloid Recurrence
Imiquimod 5% cream - Keloid
Phase 2TerminatedUniversity of Pennsylvania62019-02-052020-11-19
Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies
TAPA-pulsed DC vaccine, Cyclophosphamide Pill, Imiquimod Topical Cream - Progressive Solid Malignancies, Refractory Solid Malignancies
Phase 1 / Phase 2TerminatedKiromic BioPharma Inc.32017-07-282020-04-24
Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
Vaccine MAGE-3.A1 peptide, or the NA17.A2 peptide + IL-2, IFN-α and GMCSF, Imiquimod. - Metastatic Melanoma
Phase 1 / Phase 2TerminatedCliniques universitaires Saint-Luc- Université Catholique de Louvain22010-08-012019-03-12
The Effects of Aldara as an Adjunct to Laser Treatment
Imiquimod, non-medicated petroleum cream - Port Wine Stains
Phase 2TerminatedHenry Vasconez72008-10-012018-03-22
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
GM-CSF, Dendritic Cell/Tumor Fusion Vaccine, imiquimod - Ovarian Cancer, Primary Peritoneal Cancer
Phase 2TerminatedBeth Israel Deaconess Medical Center152008-05-012026-08-05

Conditions studied

Fallopian Tube Neoplasms (1)  ·  Hemangioma, Capillary (1)  ·  Keloid (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pigmentation Disorders (1)

Sponsors

Beth Israel Deaconess Medical Center (1)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Henry Vasconez (1)  ·  Kiromic BioPharma Inc. (1)  ·  University of Pennsylvania (1)

Countries

United States (4)  ·  Belgium (1)

Top investigators

Anthony Tolcher, MD (1)  ·  Baurain Jean-Francois, MD, PhD (1)  ·  David Avigan, MD (1)  ·  Henry C. Vasconez, MD (1)